Analyst: Arcadia sales poised to take off

Arcadia Resources’ DailyMed business will grow revenue 10-fold in the next three years and push the Indianapolis-based
company into profitability, according to a research report by the first analyst to officially cover the company.

Jeffrey Cohen, a senior research analyst at C.K. Cooper & Co., an investment banking firm near Los Angeles, issued the
report last week.

“We believe that the growth, uniqueness and savings associated with the DailyMed offering warrants further review from
the investment community,” Cohen wrote. He does not own Arcadia shares, but C.K. Cooper may seek to do investment banking
work for Arcadia in the future.

Most investors do not share Cohen's optimism. Arcadia's shares closed Tuesday at 52 cents apiece, and they are off
their 52-week high by 58 percent.

The DailyMed service packages dosages of prescription medicines into individual packets labeled with the time of day they
are to be taken. That system, combined with regular calls and coaching from nurses, are designed to make it easier for patients
on numerous medications to stick to their drug regimens.

DailyMed had 3,800 participants as of March. But Cohen expects that number to rocket to more than 48,000 by March 2013.

The reason? Arcadia’s contracts with Indianapolis-based WellPoint Inc., Minnesota-based UnitedHealth Group, and Illinois-based
Health Alliance will rapidly introduce the DailyMed service to new customers.

Those insurance companies are eager to use DailyMed to help chronically ill patients—particularly seniors—to
take their medicines consistently—thereby avoiding expensive hospitalizations.

The growth in DailyMed members would push Arcadia’s pharmacy revenue up accordingly. It made $15.2 million in that
business in the fiscal year ended in March. Cohen expects pharmacy revenue to approach $156 million for the year ending March
2013.

Revenue from Arcadia’s other businesses—home health care staffing and medical equipment sales by catalog—will
either grow modestly or remain flat, Cohen predicts.

But he expects the pharmacy growth will be enough to erase Arcadia’s perennial losses, which totaled $31 million last
year. He expects the red ink to slacken each year and then turn black in 2013, with Arcadia posting a profit of $9.3 million
that year on total revenue of $254 million.

“DailyMed represents the crown jewel in Arcadia’s coffers,” Cohen wrote.

In May, Arcadia announced a $3.9
million expansion
of its Indianapolis headquarters and pharmacy operations that are expected to add 930
jobs here by 2013. The company leases office space in the Precedent Office Park near North Keystone Avenue and East 96th Street.

Arcadia now has about 500 employees in Indiana and 4,000 nationwide who provide home health care services.

 

Please enable JavaScript to view this content.

Story Continues Below

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our updated comment policy that will govern how comments are moderated.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}